Literature DB >> 19686444

Long-term outcome and management of hepatopulmonary syndrome in children.

Abdulrahman Al-Hussaini1, Rachel M Taylor, Marianne Samyn, Sanjay Bansal, Nigel Heaton, Mohammed Rela, Giorgina Mieli-Vergani, Anil Dhawan.   

Abstract

UNLABELLED: We aim to report a single center experience of the management and long term outcome of HPS in pediatric liver transplant recipients. A retrospective review of children with HPS from 1990 to 2004. INCLUSION CRITERIA: liver disease or portal hypertension, hypoxemia (PaO(2) < 70 mmHg or SaO(2) < 95%) and intrapulmonary shunting documented by macroaggregated albumin scan ratio of >4% (classified mild group [<20%], moderate group [20-40%] and severe group [>40%]). Resolution of HPS post-liver transplant was defined as PaO(2) > 70 mmHg or SaO(2) > 95%. Eighteen children (six male [34%], median age at diagnosis of HPS 8.6 [1-15.5] yr) had HPS: biliary atresia (n = 8), idiopathic biliary cirrhosis (n = 4), progressive intrahepatic cholestasis (n = 2), miscellaneous (n = 4). The majority had mild shunting (n = 8). Fourteen underwent transplantation with resolution of HPS in 13. Six developed complications: hepatic artery thrombosis (n = 4), biliary (n = 2). Four children died (28%), two pretransplant. There was a tendency towards shunt fraction worsening to a slower degree over time. One-yr survival rate post-transplant was 93%. Median PaO(2) was significantly lower in non-survivors compared to survivors (43 vs. 55.2 mmHg, p = 0.03). There was correlation between oxygen parameters pretransplant and time to HPS resolution post-transplant. HPS is reversible after transplant, but is associated with increasing mortality and morbidity.

Entities:  

Mesh:

Year:  2009        PMID: 19686444     DOI: 10.1111/j.1399-3046.2009.01218.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  5 in total

1.  Taurine mitigates the development of pulmonary inflammation, oxidative stress, and histopathological alterations in a rat model of bile duct ligation.

Authors:  Mohammad Mehdi Ommati; Ali Mobasheri; Yanqin Ma; Dongmei Xu; Zhongwei Tang; Ram Kumar Manthari; Narges Abdoli; Negar Azarpira; Yu Lu; Issa Sadeghian; Abolghasem Mousavifaraz; Ali Nadgaran; Ahmad Nikoozadeh; Sahra Mazloomi; Pooria Sayar Mehrabani; Mohammad Rezaei; Hu Xin; Yang Mingyu; Hossein Niknahad; Reza Heidari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-09-13       Impact factor: 3.195

2.  Improved severe hepatopulmonary syndrome after liver transplantation in an adolescent with end-stage liver disease secondary to biliary atresia.

Authors:  Tae Jun Park; Keun Soo Ahn; Yong Hoon Kim; Hyungseop Kim; Ui Jun Park; Hyoung Tae Kim; Won Hyun Cho; Woo-Hyun Park; Koo Jeong Kang
Journal:  Clin Mol Hepatol       Date:  2014-03-26

Review 3.  Proposed management algorithm for severe hypoxemia after liver transplantation in the hepatopulmonary syndrome.

Authors:  D Nayyar; H S J Man; J Granton; L B Lilly; S Gupta
Journal:  Am J Transplant       Date:  2015-02-03       Impact factor: 8.086

4.  Clinical outcomes and risk factors of hepatopulmonary syndrome in children.

Authors:  Kwang Yeon Kim; Tae Hyeong Kim; Jeong-Moo Lee; Nam-Joon Yi; Hyun-Young Kim; Jin Soo Moon; Jae Sung Ko
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

5.  Refractory hypoxemia caused by hepatopulmonary syndrome: a case report.

Authors:  Morgen L Govindan; Kevin W Kuo; Maryam Ghadimi Mahani; Thomas P Shanley
Journal:  J Med Case Rep       Date:  2014-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.